Sofwave Medical Ltd.

As of June 30, 2026, Sofwave Medical Ltd. carries a market capitalization of 149.93B, placing it among publicly traded companies globally. Its enterprise value stands at 141.96B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Sofwave Medical Ltd. has 36.10M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Sofwave Medical Ltd. maintains a current ratio of 2.46, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Sofwave Medical Ltd. recorded 12.74M in income tax expense.

As of the close on October 22, 2026, Sofwave Medical Ltd.'s stock has gained approximately 15.88% over the past 52 weeks. The 50-day moving average sits at 3,432.90, while the 200-day moving average is 3,791.75.

As of June 30, 2026, Sofwave Medical Ltd. holds 8.39B in cash and equivalents against 422.96M in total debt, resulting in a net debt position of -8.37B. Total book value stands at 11.27B, with working capital of 10.04B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.